Back to search

Article

Serglycin as a Preliminary Candidate Biomarker in GNE Myopathy Associated with Impaired Secretion and Autophagy Dysregulation

2026-06-13

Abstract excerpt

<title>Abstract</title> <p> GNE myopathy (GNEM) is a neuromuscular disorder caused by biallelic mutations in the gene <italic>GNE</italic> , which encodes a bifunctional enzyme essential for the biosynthesis of sialic acid. Despite extensive characterization, no effective therapies or validated biomarkers exist, and the molecular mechanisms driving disease pathology remain poorly understood. This study identif...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
64a16283-724d-5f78-be5f-09ac2b55d3b8
DOI
10.21203/rs.3.rs-9791335/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Serglycin as a Preliminary Candidate Biomarker in GNE Myopathy Associated with Impaired Secretion and Autophagy DysregulationDOI 10.21203/rs.3.rs-9791335/v1
Select a neighboring publication to make it the new centre.